NEW YORK, NY / ACCESSWIRE / June 10, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Conn's, Inc. (NASDAQ:CONN)
CONTACT JAKUBOWITZ ABOUT CONN:
https://claimyourloss.com/securities/conns-inc-loss-submission-form/?id=7273&from=1
Class Period: September 3, 2019 - December 9, 2019
Lead Plaintiff Deadline: July 14, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Conn's was experiencing an increase in first payment defaults and 60-plus day delinquencies; (2) as a result, Conn's was reasonably likely to record an increase to its provision for bad debts; (3) the Company made certain underwriting adjustments, including tightening its standards for new customers and online applicants; (4) as a result, the Company's same-store sales would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
CONTACT JAKUBOWITZ ABOUT SRNE:
https://claimyourloss.com/securities/sorrento-therapeutics-inc-loss-submission-form/?id=7273&from=1
Class Period: May 15, 2020 - May 22, 2020
Lead Plaintiff Deadline: July 27, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Carnival Corporation & Plc (NYSE:CCL)
CONTACT JAKUBOWITZ ABOUT CCL:
https://claimyourloss.com/securities/carnival-corporation-loss-submission-form/?id=7273&from=1
Class Period : September 26, 2019 - May 1, 2020
Lead Plaintiff Deadline: July 27, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's medics were reporting increasing events of COVID-19 illness on the Company's ships; (2) Carnival was violating port of call regulations by concealing the amount and severity of COVID-19 infections on board its ships; (3) in responding to the outbreak of COVID-19, Carnival failed to follow the Company's own health and safety protocols developed in the wake of other communicable disease outbreaks; (4) by continuing to operate, Carnival ships were responsible for continuing to spread COVID-19 at various ports throughout the world; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/593482/LAWSUITS-FILED-AGAINST-CONN-SRNE-and-CCL--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS